ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma

Ming, Jie; Wang, Chunyang*哈尔滨医科大学; 1
Frontiers in Genetics2022-4-13DOI: 10.3389/fgene.2022.871899
16被引9阅读
引用收藏
分享

摘要

N7-Methylguanosine (m7G) and long non-coding RNAs (lncRNAs) have been widely reported to play an important role in cancer. However, there is little known about the relationship between m7G-related lncRNAs and clear cell renal cell carcinoma (ccRCC). To find new potential biomarkers and construct an m7G-related lncRNA prognostic signature for ccRCC, we retrieved transcriptome data and clinical data from The Cancer Genome Atlas (TCGA), and divided the entire set into train set and test set with the ratio of 1:1 randomly. The m7G-related lncRNAs were identified by Pearson correlation analysis (|coefficients| > 0.4, and p < 0.001). Then we performed the univariate Cox regression and least absolute shrinkage and selection operator (LASSO) Cox regression analysis to construct a 12 m7G-related lncRNA prognostic signature. Next, principal component analysis (PCA), the Kaplan-Meier method, time-dependent receiver operating characteristics (ROC) were made to verify and evaluate the risk signature. A nomogram based on the risk signature and clinical parameters was developed and showed high accuracy and reliability for predicting the overall survival (OS). Functional enrichment analysis (GO, KEGG and GSEA) was used to investigate the potential biological pathways. We also performed the analysis of tumor mutation burden (TMB), immunological analysis including immune scores, immune cell infiltration (ICI), immune function, tumor immune escape (TIE) and immunotherapeutic drug in our study. In conclusion, using the 12 m7G-related lncRNA risk signature as a prognostic indicator may offer us insight into the oncogenesis and treatment response prediction of ccRCC.

学科与关键词

关键词
clear cell renal cell carcinomaN7-methylguanosinelncRNAprognosistumor microenvironmenttumor mutation burden
相关
加载中…
  • A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma
    Zhang, Zedan; Tang, Yanlin; Liu, Yanjun; Zhuang, Hongkai; Lin, Enyu; Xie, Lu; Feng, Xiaoqiang; Tian, Kaiwen; Zeng, Jiayi; Liu, Jiumin; Yu, Yuming*Journal of Immunology Research, 2021, 2021: 9921466.被引 10
  • The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma
    Zhang, Wei; Liu, Zhiming; Wang, Jinpeng; Geng, Bo; Hou, Wenbin; Zhao, Enyang*; Li, Xuedong*Frontiers in Immunology, 2022, 13: 934387.被引 3
  • Construction and Characterization of n6-Methyladenosine-Related lncRNA Prognostic Signature and Immune Cell Infiltration in Kidney Renal Clear Cell Carcinoma
    Chen, Zerong; Huang, Zehai; Hui, Jialiang; Chen, Zhuangfei; Zhang, Haibo; Jiang, Yaodong*; Zeng, Weisen*Journal of Oncology, 2022, 2022: 7495183.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-04-13
卷期
第 13 卷
页码
871899
DOI
10.3389/fgene.2022.871899
期刊等级
3区
成果收录
SCIE
资助标注
First Affiliated Hospital of Harbin Medical University Fund for Distinguished Young Medical Scholars [HYD2020JQ0020]

作者

  • M

    Ming, Jie (第一作者)

    1 · harbin med univ

  • W

    Wang, Chunyang (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417